Mark Salvati
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
-
- Prostate Cancer Treatment and Research
- Lung Cancer Treatments and Mutations
Papers in
-
- Prostate Cancer Treatment and Research 16
- Oncology 11
- Cancer Immunotherapy and Biomarkers 9
- Co-authors
- Ricardo M. Attar (9 shared papers)Roberto Simon Weinmann (5 shared papers)Stanley R. Krystek (5 shared papers)Yongmi An (3 shared papers)John S. Sack (3 shared papers)Kevin Kish (2 shared papers)Chihuei Wang (2 shared papers)Robert W. Armstrong (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (11 papers)Blood (5 papers)Cancer Research (4 papers)Journal of Medicinal Chemistry (3 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
Mark Salvati
42 papers receiving 2.2k citations
Mark Salvati's Hit Papers
Peers
Comparison fields: 5 of 72
- Oncology 891
- Pulmonary and Respiratory Medicine 610
- Organic Chemistry 259
- Computational Theory and Mathematics 118
- Endocrinology, Diabetes and Metabolism 96
Countries citing papers authored by Mark Salvati
This map shows the geographic impact of Mark Salvati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Salvati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Salvati more than expected).
Fields of papers citing papers by Mark Salvati
This network shows the impact of papers produced by Mark Salvati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Salvati. The network helps show where Mark Salvati may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Salvati, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer Hit paper breakdown → | 2015 | 1011 |
| 2 | 2001 | 392 | |
| 3 | 1992 | 104 | |
| 4 | 2010 | 100 | |
| 5 | 2004 | 57 | |
| 6 | 2006 | 51 | |
| 7 | 2022 | 49 | |
| 8 | 2009 | 45 | |
| 9 | 2004 | 39 | |
| 10 | 2024 | 32 | |
| 11 | 2008 | 31 | |
| 12 | 2010 | 29 | |
| 13 | 2004 | 28 | |
| 14 | 2016 | 28 | |
| 15 | 2008 | 26 | |
| 16 | 2012 | 23 | |
| 17 | 2005 | 22 | |
| 18 | 2007 | 21 | |
| 19 | 2007 | 21 | |
| 20 | 2012 | 20 |
About Mark Salvati
Mark Salvati is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Organic Chemistry, Hematology and Pharmaceutical Science, having authored 46 papers that have together received 2.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (16 papers), Synthesis and biological activity (10 papers), Cancer Immunotherapy and Biomarkers (9 papers), Cholesterol and Lipid Metabolism (7 papers), Acute Myeloid Leukemia Research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Lipoproteins and Cardiovascular Health (3 papers) and Synthesis and pharmacology of benzodiazepine derivatives (2 papers). The work is most often cited by research in Oncology (891 citations), Pulmonary and Respiratory Medicine (610 citations), Organic Chemistry (259 citations), Computational Theory and Mathematics (118 citations) and Endocrinology, Diabetes and Metabolism (96 citations). Mark Salvati has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Ricardo M. Attar, Roberto Simon Weinmann, Stanley R. Krystek, Yongmi An, John S. Sack, Kevin Kish, Chihuei Wang, Robert W. Armstrong, Julie E. Scheffler and Susan E. Kiefer. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Blood, Cancer Research, Journal of Medicinal Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.